(216 days)
No
The summary describes standard dental prosthetic components and their testing, with no mention of AI or ML capabilities.
No.
The device is a prosthetic component for dental implant rehabilitations, aiding in restoring function and aesthetics, rather than directly treating a disease or condition.
No
Explanation: The device description and intended use clearly state that these are prosthetic components used for dental rehabilitations, such as temporary and final abutments. Their function is to aid in prosthetic rehabilitations by maintaining, stabilizing, and shaping soft tissue or supporting restorations, not to diagnose a condition.
No
The device description clearly states the devices are "prosthetic components" and describes physical testing (biocompatibility, sterilization, bench testing), indicating they are hardware, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for prosthetic rehabilitations directly connected to dental implants. This is a surgical/dental procedure, not a diagnostic test performed on samples from the human body.
- Device Description: The device is described as prosthetic components for dental implants.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
- Performance Studies: The performance studies focus on biocompatibility, sterilization, and mechanical bench testing, which are typical for implantable or prosthetic devices, not IVDs.
IVD devices are specifically designed to be used in vitro (outside the body) to analyze biological samples for diagnostic purposes. This device is used in vivo (within the body) as a prosthetic component.
N/A
Intended Use / Indications for Use
Prosthetic components directly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. Temporary components can be used prior to the final components to maintain, stabilize and shape the soft tissue during the healing phase; they are to be placed out of occlusion. Final abutments may be placed into occlusion for implants with sufficient primary stability or for implants that are fully osseointegrated.
Temporary Abutments have a maximum duration of usage of 180 days.
Product codes (comma separated list FDA assigned to the subject device)
NHA
Device Description
The subject devices described in the submission are prosthetic components that are intended for use in prosthetic rehabilitations, directly or indirectly connected to the endosseous dental implant. These devices are intended for use as an aid in prosthetic rehabilitations. The subject devices described in this submission are to be added Straumann's existing prosthetic portfolio.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility Testing
Biological assessment has been performed according to ISO 10993-1:2009 "Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process" and to the FDA Guidance document "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process'. Guidance for Industry and Food and Drug Administration Staff, Document issued on: June 16, 2016" for each of the subject devices.
The assessment concluded the subject devices are equivalent in regards to nature of body contact, contact duration, material formulation and sterilization methods compared to the primary and reference predicate devices and therefore no new testing has been performed.
Sterilization
The Screw-Retained Abutments are provided to the end user as sterile via gamma irradiation. The proposed Screw-Retained Abutments production process are identical to the screw-retained abutments cleared per K171757. A sterilization validation assessment was performed according to ISO 11137. The assessment concluded the proposed Screw-Retained Abutments can be adopted into the same sterilization process validated for the Screw-Retained Abutments cleared per K171757.
The packaging of the Straumann® Screw-Retained Abutments is identical to the packaging of the reference devices cleared per K171757. There are no changes to the sterilization method or production process compared to the reference devices. The shelf life for the proposed Screw-Retained Abutments will remain 5 years.
Bench Testing
Dynamic fatigue, static strength, and torque tests were conducted according to the FDA guidance document "Guidance for Industry and FDA Staff – Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments" and demonstrated the Straumann Screw-retained Abutments is equivalent to the predicate and reference devices.
Dynamic fatigue (and static strength) tests were performed to evaluate the fatigue load limits of the proposed Straumann Screw-retained Abutments. Based on worst-case considerations, both platforms straight and angled abutments were tested and shown to be equivalent to the reference predicate device K072497.
Clinical data
No device specific clinical data has been submitted to demonstrate substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K171757, K133421, K190662, K072497
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
0
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
April 6, 2020
Straumann USA, LLC Chanrasmey White Regulatory Affairs Specialist 60 Minuteman Road Andover, Massachusetts 01810
Re: K192401
Trade/Device Name: Straumann® Screw-Retained Abutments Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: March 5, 2020 Received: March 6, 2020
Dear Chanrasmey White:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Srinivas Nandkumar, Ph.D. for Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name
Straumann® Screw-Retained Abutments
Indications for Use (Describe)
Prosthetic components directly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. Temporary components can be used prior to the final components to maintain, stabilize and shape the soft tissue during the healing phase; they are to be placed out of occlusion. Final abutments may be placed into occlusion for implants with sufficient primary stability or for implants that are fully osseointegrated.
Temporary Abutments have a maximum duration of usage of 180 days.
Type of Use (Select one or both, as applicable) 図Prescription Use (Part 21 CFR 801 Subpart D)
□Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.
3
Straumann® Screw-Retained Abutments
510(k) Summary
510(k) Summary 5
Submitter 5.1
Straumann USA, LLC (on behalf of Institut Straumann AG)
60 Minuteman Road
Andover, MA 01810
| Phone Number: | 978-747-2614 |
|---|---|
| --------------- | -------------- |
Fax Number: 978-747-0023
Contact Person: Chanrasmey White
Date of Submission: April 02, 2020
5.2 Device
| Trade Name: | Straumann® Screw-Retained Abutments |
|---|---|
| Common Name: | Endosseous Dental Implant Abutments |
| Classification Name: | Endosseous Dental Implant Abutments |
| Regulatory Class: | II (21 CFR 872.3630) |
| Product Code: | NHA (21 CFR 872.3630) |
5.3 Predicate Device
Primary Predicate:
-
K181703 BLX Implant System .
Reference Predicate: -
K171757 Straumann® Screw Retained Abutments .
-
K133421 Straumann® Magellan™ Screw Retained Abutment System ●
-
. K190662 – MRI Compatibility for Existing Straumann Dental Implant Systems
-
K072497 NC Gold Abutment For Crowns .
5.4 Device Description
The subject devices described in the submission are prosthetic components that are intended for use in prosthetic rehabilitations, directly or indirectly connected to the
4
Straumann® Screw-Retained Abutments
510(k) Summary
endosseous dental implant. These devices are intended for use as an aid in prosthetic rehabilitations. The subject devices described in this submission are to be added Straumann's existing prosthetic portfolio.
5.4.1 Straumann® Screw-Retained Abutments
Straumann® Screw-Retained Abutments or SRAs include straight and angled (17° and 30°) abutments, basal screws and abutment carrier pin. The proposed Screw-Retained abutments are equivalent to the Screw-Retained Abutments cleared per K133421. The proposed Screw-Retained Abutments production processes are identical to Screw-Retained Abutments cleared per K171757. The new design of the straight Screw-Retained Abutment and smoothened angled Screw-Retained Abutments for Bone Level lmplants are similar the Screw-Retained Abutments for BLX implants cleared per K181703.
5.4.2 Straumann® Temporary Copings
Straumann temporary copings are compatible with Straumann® Screw-Retained Abutments and are used for temporary restorations of single crowns and bridges. The copings are placed on dental abutments to support temporary prosthetic superstructures. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they are to be placed out of occlusion. The temporary copings may be customized by the dentist to fit the oral situation and are then secured to a compatible abutment by screw fixation. The subject device is similar to the temporary copings cleared per K133421.
5.4.3 Straumann® Protective Cap
Straumann® Protective Caps are placed to the Straumann® Screw-Retained Abutments and intended to be used to protect the abutment configuration and maintain, stabilize and form the soft tissue during the healing process. The subject device is similar to the protective caps cleared per K133421.
5
Straumann® Screw-Retained Abutments
510(k) Summary
5.5 Indications for Use
Prosthetic components directly or indirectly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they are to be placed out of occlusion. Final abutments may be placed into occlusion for implants with sufficient primary stability or for implants that are fully osseointegrated.
Temporary Abutments have a maximum duration of usage of 180 days.
5.6 Technological Characteristics
5.6.1 Straumann® Screw-Retained Abutments
The straight and smoothened angled Screw-Retained Abutments are made of Ti-6Al-7Nb (TAN) and designed to be used together with Straumann® Bone Level Implants having either NC (Narrow CrossFit) or RC (Regular CrossFit) connections. SRAs are laser engraved with either NC or RC to specify the implant type. SRAs are anodized blue for NC Ø3.5 mm and yellow for NC Ø4.6 mm. RC abutments are non-anodized. SRA straight abutments do not contain an anti-rotational feature, allowing the abutment to be screwed directly into the implant. Smoothened angled SRAs are connected to the implant by a basal screw. The proposed abutments will be delivered to the end user sterile via gamma irradiation.
The proposed Screw-Retained Abutments are equivalent to the Screw-Retained Abutments cleared per K133421 and K171757. The proposed Screw-Retained Abutments production processes are identical to screw-retained abutments cleared per K171757 with a new design. The new design, straight Screw-Retained Abutments and smoothened angled Screw-Retained Abutments for Bone Level Implants are similar in regards to design to the Screw-Retained Abutments for BLX cleared per K181703. Premarket notification K190662 is included as a reference device to address MRI compatibility. Premarket notification K072497 is included as a reference device for comparison of dynamic fatigue.
The technological characteristics of the proposed Screw Retained Abutments are compared to the primary and reference devices in Table 1.
6
Straumann® Screw-Retained Abutments
510(k) Summary
5.6.2 Straumann® Temporary Copings for Screw-Retained Abutments
Temporary Copings are placed on dental abutments to support temporary prosthetic superstructures. Temporary copings in combination with the implant, abutment and temporary superstructure are used to restore function in patients missing a tooth or teeth for a temporary period. This commonly occurs during the healing and soft tissue management phase after implants are placed. Temporary restorations are not intended for receiving occlusal load from opposing dentition. This temporary solution to a missing tooth is later replaced by the final restoration.
The proposed temporary coping is designed for easier reworking at the dentist office. The proposed temporary coping will have a reduced wall thickness than temporary copings cleared per K133421.
The technological characteristics of the proposed Screw Retained Abutments are compared to the primary and reference devices in Table 2.
5.6.3 Straumann® Protective Caps for Screw-Retained Abutments
Protective caps are placed to the Screw-Retained Abutment and intended to be used to protect the abutment configuration and maintain, stabilize and form the soft tissue during the healing process. The proposed protective caps are made available with a width of 3.5 mm and 4.6 mm. The proposed protective caps are similar to the protective caps cleared per K133421 for Screw-Retained Abutments. The difference is a change in design from a columnar shape to a mushroom shape of the polymer body. The proposed protective caps are made out of PEEK and a screw made out of titanium alloy. The proposed protective caps are to be provided to the end user as non-sterile.
The technological characteristics of the proposed Screw Retained Abutments are compared to the primary and reference devices in Table 3.
7
Straumann® Screw-Retained Abutments
510(k) Summary
| FEATURE | PROPOSED DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE DEVICE | REFERENCE DEVICE |
|---|---|---|---|---|
| K Number | Subject Device | K181703 | K171757 | K133421 |
| Indications for | ||||
| Use | Prosthetic components directly or | |||
| indirectly connected to the | ||||
| endosseous dental implant are | ||||
| intended for use as an aid in | ||||
| prosthetic rehabilitations. Temporary | ||||
| components can be used prior to the | ||||
| insertion of the final components to | ||||
| maintain, stabilize and shape the | ||||
| soft tissue during the healing phase; | ||||
| they are to be placed out of | ||||
| occlusion. Final abutments may be | ||||
| placed into occlusion for implants | ||||
| with sufficient primary stability or for | ||||
| implants that are fully | ||||
| osseointegrated. | ||||
| Temporary Abutments have a | ||||
| maximum duration of usage of 180 | ||||
| days. | Prosthetic components directly or | |||
| indirectly connected to the | ||||
| endosseous dental implant are | ||||
| intended for use as an aid in | ||||
| prosthetic rehabilitations. Temporary | ||||
| components can be used prior to the | ||||
| insertion of the final components to | ||||
| maintain, stabilize and shape the | ||||
| soft tissue during the healing phase; | ||||
| they may not be placed into | ||||
| occlusion. Final abutments may be | ||||
| placed into occlusion when the | ||||
| implant is fully osseointegrated. | ||||
| BLX Temporary Abutments have a | ||||
| maximum duration of usage of 180 | ||||
| days. | Straumann® Screw Retained | |||
| Abutments are indicated to be | ||||
| placed into the implants of the | ||||
| Straumann® Dental Implant System | ||||
| to provide support for prosthetic | ||||
| reconstructions such as crowns, | ||||
| bridges and bars. The final | ||||
| processed devices have the | ||||
| purpose of restoring chewing | ||||
| function. Straumann® Screw | ||||
| Retained Abutments are indicated | ||||
| for screw-retained restorations. | Magellan™ abutments are indicated | |||
| to be placed into dental implants to | ||||
| provide support for prosthetic | ||||
| reconstructions such as crown, | ||||
| bridges and bars. The final | ||||
| processed devices have the | ||||
| purpose of restoring chewing | ||||
| function. | ||||
| Material | Ti-6Al-7Nb | Ti-6Al-7Nb | Ti-6Al-7Nb | Ti-6Al-7Nb |
| Implant to | ||||
| Abutment | ||||
| Connection | CrossFit® (NC and RC) | |||
| (with conical fitting) | BLX | |||
| (with conical fitting) | CrossFit® (NC and RC) | |||
| (with conical fitting) | CrossFit® (NC and RC) | |||
| (with conical fitting) | ||||
| Restoration Type | Single and Multi | |||
| (Straight NC GH 1.0 mm (ø 3.5 mm | ||||
| and Ø4.6 mm), are indicated for | ||||
| single-crown restorations in central | ||||
| and lateral incisors, and for multi- | ||||
| unit restorations in incisors to pre- | ||||
| molars) | Single and Multi | |||
| (Straight NC GH 1.0 mm (ø 3.5 mm | ||||
| and Ø4.6 mm), are indicated for | ||||
| single-crown restorations in central | ||||
| and lateral incisors, and for multi- | ||||
| unit restorations in incisors to pre- | ||||
| molars) | Single and Multi | |||
| (Straight NC GH 1.0 mm (ø 3.5 mm | ||||
| and Ø4.6 mm), are indicated for | ||||
| single-crown restorations in central | ||||
| and lateral incisors, and for multi- | ||||
| unit restorations in incisors to pre- | ||||
| molars) | Single and Multi | |||
| (Straight NC GH 1.0 mm (ø 3.5 mm | ||||
| and Ø4.6 mm), are indicated for | ||||
| single-crown restorations in central | ||||
| and lateral incisors, and for multi- | ||||
| unit restorations in incisors to pre- | ||||
| molars) | ||||
| Indexing type / | ||||
| presence | Straight - Non Engaging | |||
| Angled - Engaging | Straight - Non Engaging | |||
| Angled - Engaging | Engaging | Engaging | ||
| Surface Treatment | ||||
| / Anodization | 3.5 NC Straight - Blue | |||
| 4.6 NC Straight and Angled - Yellow | ||||
| 4.6 RC Straight and Angled - Grey | RB & WB - Magenta | 3.5 NC Straight - Blue | ||
| 4.6 NC Straight and Angled - Yellow | ||||
| 4.6 RC Straight and Angled - Grey | 3.5 NC Straight - Blue | |||
| 4.6 NC Straight and Angled - Yellow | ||||
| 4.6 RC Straight and Angled - Grey | ||||
| Duration of Use | unlimited | unlimited | unlimited | unlimited |
| Platform Diameter | Ø3.5 and 4.6 mm | Ø4.6 mm | Ø3.5 and 4.6 mm | Ø3.5 and 4.6 mm |
| Gingival Heights | 1.5, 2.5, 3.5, 4.5 and 5.5 mm | 1.5, 2.5, 3.5 and 4.5 mm | 1.0, 2.5, 4.0 and 5.5 mm | 1.0, 2.5 and 4.0 mm |
| FEATURE | PROPOSED DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE DEVICE | REFERENCE DEVICE |
| K Number | Subject Device | K181703 | K171757 | K133421 |
| Angulation | 0°, 17°, and 30° | 0°, 17°, and 30° | 0°, 17°, and 30° | 0°, 17°, and 30° |
| Sterilization | ||||
| Method | Gamma Irradiation | Gamma Irradiation | Gamma Irradiation | Non-sterile/ End user sterilized |
| Prosthesis Type | Screw-retained | Screw-retained | Screw-retained | Screw-retained |
| Sterilization | Sterile - Gamma Irradiation | Sterile - Gamma Irradiation | Sterile - Gamma Irradiation | Non-Sterile |
| End User - Steam Autoclave |
8
Straumann® Screw-Retained Abutments
510(k) Summary
Table 1 – Comparison Matrix – Screw Retained Abutments
9
Straumann® Screw-Retained Abutments
510(k) Summary
| FEATURE | PROPOSED DEVICE | REFERENCE DEVICE |
|---|---|---|
| K Number | Subject Device | K133421 |
| Indications for Use | Prosthetic components directly or indirectly connected to the | |
| endosseous dental implant are intended for use as an aid in | ||
| prosthetic rehabilitations. Temporary components can be used | ||
| prior to the insertion of the final components to maintain, | ||
| stabilize and shape the soft tissue during the healing phase; | ||
| they are to be placed out of occlusion. Final abutments may be | ||
| placed into occlusion for implants with sufficient primary stability | ||
| or for implants that are fully osseointegrated. | ||
| Temporary Abutments have a maximum duration of usage of | ||
| 180 days. | Maqellan™ abutments are indicated to be placed into dental | |
| implants to provide support for prosthetic reconstructions such | ||
| as crown, bridges and bars. The final processed devices have | ||
| the purpose of restoring chewing function. | ||
| Material | Ti-6Al-7Nb | Ti-6Al-7Nb |
| Abutment Connection | Crown - Engaging | |
| Bridges / Bars - Non Engaging | Crown - Engaging | |
| Bridges / Bars - Non Engaging | ||
| Temporary Coping Diameter | 3.5 mm (NC) | |
| 4.6 mm (NC and RC) | 3.5 mm (NC) | |
| 4.6 mm (NC and RC) | ||
| Temporary Coping Material | Ti-6Al-7Nb (TAN) | Titanium Grade 4 |
| Duration | 180 Days | Unlimited |
| Chimney Design | ||
| 3.5 NC | Inner Diameter: 2.3 | |
| Outer Diameter: 2.6 | Inner Diameter 2.3 | |
| Outer Diameter 3.0 | ||
| Chimney Design | ||
| 4.6 NC and RC | Inner Diameter: 2.3 | |
| Outer Diameter: 2.6 | Inner Diameter: 2.3 | |
| Outer Diameter: 3.4 | ||
| Temporary Coping Sterilization Method | Non-Sterile | |
| End User - Steam Autoclave | Non-Sterile | |
| End User - Steam Autoclave |
Table 2 – Comparison Matrix – Temporary Copings
10
Straumann® Screw-Retained Abutments
510(k) Summary
| FEATURE | PROPOSED DEVICE | REFERENCE DEVICE |
|---|---|---|
| K Number | Subject Device | K133421 |
| Indications for Use | Prosthetic components directly or indirectly connected to the | |
| endosseous dental implant are intended for use as an aid in | ||
| prosthetic rehabilitations. Temporary components can be used | ||
| prior to the insertion of the final components to maintain, stabilize | ||
| and shape the soft tissue during the healing phase; they are to be | ||
| placed out of occlusion. Final abutments may be placed into | ||
| occlusion for implants with sufficient primary stability or for | ||
| implants that are fully osseointegrated. | ||
| Temporary Abutments have a maximum duration of usage of 180 | ||
| days. | Magellan™ abutments are indicated to be placed into dental | |
| implants to provide support for prosthetic reconstructions such as | ||
| crown, bridges and bars. The final processed devices have the | ||
| purpose of restoring chewing function. | ||
| Protective Cap Diameter | 3.5 mm (NC) | 3.5 mm (NC) |
| 4.6 mm (NC and RC) | 4.6 mm (NC and RC) | |
| Protective Cap Height | 5mm | 5mm, 6.5mm and 8mm |
| Protective Cap Material | polyetheretherketone (PEEK) cap and Ti-6AI-7Nb (TAN) screw | polyetheretherketone (PEEK) cap and Ti-6AI-7Nb (TAN) screw |
| Shape | Mushroom design | Columnar design |
| Duration | 180 days | 180 days |
| Protective Cap Sterilization Method | Non-Sterile | Non-Sterile |
| End User - Steam Autoclave | End User – Steam Autoclave |
Table 3 – Comparison Matrix – Protective Caps
11
Straumann® Screw-Retained Abutments
510(k) Summary
5.7 Performance Data
The following performance data has been provided in support of the substantial equivalence determination. A summary is provided below.
5.7.1 Biocompatibility Testing
Biological assessment has been performed according to ISO 10993-1:2009 "Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process" and to the FDA Guidance document "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process'. Guidance for Industry and Food and Drug Administration Staff, Document issued on: June 16, 2016" for each of the subject devices.
The assessment concluded the subject devices are equivalent in regards to nature of body contact, contact duration, material formulation and sterilization methods compared to the primary and reference predicate devices and therefore no new testing has been performed.
5.7.2 Sterilization
The Screw-Retained Abutments are provided to the end user as sterile via gamma irradiation. The proposed Screw-Retained Abutments production process are identical to the screw-retained abutments cleared per K171757. A sterilization validation assessment was performed according to ISO 11137. The assessment concluded the proposed Screw-Retained Abutments can be adopted into the same sterilization process validated for the Screw-Retained Abutments cleared per K171757.
The packaging of the Straumann® Screw-Retained Abutments is identical to the packaging of the reference devices cleared per K171757. There are no changes to the sterilization method or production process compared to the reference devices. The shelf life for the proposed Screw-Retained Abutments will remain 5 years.
5.7.3 Bench Testing
Dynamic fatigue, static strength, and torque tests were conducted according to the FDA guidance document "Guidance for Industry and FDA Staff – Class II Special Controls
12
Straumann® Screw-Retained Abutments
510(k) Summary
Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments" and demonstrated the Straumann Screw-retained Abutments is equivalent to the predicate and reference devices.
Dynamic fatigue (and static strength) tests were performed to evaluate the fatigue load limits of the proposed Straumann Screw-retained Abutments. Based on worst-case considerations, both platforms straight and angled abutments were tested and shown to be equivalent to the reference predicate device K072497.
5.7.4 Clinical data
No device specific clinical data has been submitted to demonstrate substantial equivalence.
5.8 Conclusion
The documentation submitted in this premarket notification demonstrates the subject devices are substantially equivalent to the primary predicate and reference devices.